Held LM[au] - Search Results

Year	Number of Results
2000	1
2005	1
2006	2
2007	2
2008	2
2009	2
2023	0

1

Treatment of metastatic gestational trophoblastic neoplasia.

El-Helw LM, Hancock BW. El-Helw LM, et al. Lancet Oncol. 2007 Aug;8(8):715-24. doi: 10.1016/S1470-2045(07)70239-5. Lancet Oncol. 2007. PMID: 17679081 Review.

2

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

El-Helw LM, Hancock BW. El-Helw LM, et al. Future Oncol. 2009 May;5(4):445-53. doi: 10.2217/fon.09.13. Future Oncol. 2009. PMID: 19450173 Review.

3

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

El-Helw LM, Hancock BW. El-Helw LM, et al. Expert Opin Investig Drugs. 2007 Oct;16(10):1683-91. doi: 10.1517/13543784.16.10.1683. Expert Opin Investig Drugs. 2007. PMID: 17922631 Review.

4

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia.

El-Helw LM, Seckl MJ, Haynes R, Evans LS, Lorigan PC, Long J, Kanfer EJ, Newlands ES, Hancock BW. El-Helw LM, et al. Br J Cancer. 2005 Sep 19;93(6):620-1. doi: 10.1038/sj.bjc.6602771. Br J Cancer. 2005. PMID: 16222307 Free PMC article.

5

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.

El-Helw LM, Coleman RE, Everard JE, Tidy JA, Horsman JM, Elkhenini HF, Hancock BW. El-Helw LM, et al. Gynecol Oncol. 2009 Jun;113(3):306-11. doi: 10.1016/j.ygyno.2009.02.006. Epub 2009 Mar 9. Gynecol Oncol. 2009. PMID: 19269684

6

Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.

Zekri JM, El-Helw LM, Purohit OP, Hatton MQ, Coleman RE. Zekri JM, et al. Among authors: el helw lm. Clin Oncol (R Coll Radiol). 2008 Sep;20(7):513-6. doi: 10.1016/j.clon.2008.03.016. Epub 2008 Jun 2. Clin Oncol (R Coll Radiol). 2008. PMID: 18513930

7

High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours.

El-Helw LM, Naik JD, Chester JD, Joffe JK, Selby PJ, Coleman RE. El-Helw LM, et al. BJU Int. 2006 Sep;98(3):519-25. doi: 10.1111/j.1464-410X.2006.06389.x. BJU Int. 2006. PMID: 16925746

8

Small-cell lung cancer: 8 years experience of a single multidisciplinary team.

El-Helw LM, Rogers TK, Hatton MQ. El-Helw LM, et al. J Oncol. 2008;2008:150760. doi: 10.1155/2008/150760. Epub 2008 Oct 16. J Oncol. 2008. PMID: 19266081 Free PMC article.

9

VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.

El Helw LM, Lorigan PC, Robinson MH, Coleman RE, Hancock BW. El Helw LM, et al. Int J Oncol. 2000 Apr;16(4):777-82. doi: 10.3892/ijo.16.4.777. Int J Oncol. 2000. PMID: 10717248

10

Evaluation of some biochemical markers as prognostic factors in malignant lymphomas.

Salem HA, Eissa LA, Rabbie AM, El-Helw LM, El-Gayar AM. Salem HA, et al. Among authors: el helw lm. Pak J Pharm Sci. 2006 Jul;19(3):219-30. Pak J Pharm Sci. 2006. PMID: 16935830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results